Cargando…

Effectiveness of Oxygen and Other Acute Treatments for Cluster Headache: Results From the Cluster Headache Questionnaire, an International Survey

OBJECTIVE: To assess the effectiveness and adverse effects of acute cluster headache medications in a large international sample, including recommended treatments such as oxygen, commonly used medications such as opioids, and emerging medications such as intranasal ketamine. Particular focus is paid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pearson, Stuart M., Burish, Mark J., Shapiro, Robert E., Yan, Yuanqing, Schor, Larry I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Submissions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590636/ https://www.ncbi.nlm.nih.gov/pubmed/30632614 http://dx.doi.org/10.1111/head.13473

Ejemplares similares

Cluster headache is one of the most intensely painful human conditions: Results from the International Cluster Headache Questionnaire
por: Burish, Mark J., et al.
Publicado: (2020)

Chronobiology and Sleep in Cluster Headache
por: de Coo, Ilse F., et al.
Publicado: (2019)

The Neuropsychology of Cluster Headache: Cognition, Mood, Disability, and Quality of Life of Patients With Chronic and Episodic Cluster Headache
por: Torkamani, Mariam, et al.
Publicado: (2015)

A brief diagnostic screen for cluster headache: Creation and initial validation of the Erwin Test for Cluster Headache
por: Parakramaweera, Randika, et al.
Publicado: (2021)

Aura in Cluster Headache: A Cross‐Sectional Study
por: de Coo, Ilse F., et al.
Publicado: (2018)

Analysis of HCRTR2 Gene Variants and Cluster Headache in Sweden
por: Fourier, Carmen, et al.
Publicado: (2019)

Enlarging the spectrum of cluster headache: Extracranial autonomic involvement revealed by voice analysis
por: Silvestro, Marcello, et al.
Publicado: (2021)

Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment
por: Láinez, Miguel J. A., et al.
Publicado: (2021)

The teaching of headache medicine in France: A questionnaire‐based study
por: Beltramone, Marion, et al.
Publicado: (2022)

Screening of Two ADH4 Variations in a Swedish Cluster Headache Case–Control Material
por: Fourier, Carmen, et al.
Publicado: (2016)

Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in U.S. Healthcare Claims Data
por: Choong, Casey K., et al.
Publicado: (2017)

Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache
por: Marmura, Michael J., et al.
Publicado: (2021)

Long‐Term Outcome of Patients With Intractable Chronic Cluster Headache Treated With Injection of Onabotulinum Toxin A Toward the Sphenopalatine Ganglion – An Observational Study
por: Aschehoug, Irina, et al.
Publicado: (2018)

Oxygen Therapy in Cluster Headache, Migraine, and Other Headache Disorders
por: Mo, Heejung, et al.
Publicado: (2022)

Non–Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double‐Blind, Sham‐Controlled ACT1 Study
por: Silberstein, Stephen D., et al.
Publicado: (2016)

Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache
por: Kudrow, David, et al.
Publicado: (2020)

Duration and characteristics of persistent headache following aneurysmal subarachnoid hemorrhage
por: Gaastra, Ben, et al.
Publicado: (2022)

Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult‐to‐Treat Migraine Headaches
por: Tepper, Stewart J., et al.
Publicado: (2019)

Management of migraine headaches in a chronic pain patient: A case report
por: Bach, Linda Lu, et al.
Publicado: (2016)

Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
por: Yiangou, Andreas, et al.
Publicado: (2020)

The Effect of Psychiatric Comorbidities on Headache‐Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Lipton, Richard B., et al.
Publicado: (2020)

A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine
por: Winner, Paul K., et al.
Publicado: (2020)

Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine
por: Ashina, Messoud, et al.
Publicado: (2021)

The role of oxygen in cluster headache
por: Guo, Xiao-Ning, et al.
Publicado: (2019)

Severe Headache or Migraine History Is Inversely Correlated With Dietary Sodium Intake: NHANES 1999–2004
por: Pogoda, Janice M., et al.
Publicado: (2016)

FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
por: Rothrock, John F., et al.
Publicado: (2019)

Cluster Headache Impact Questionnaire (CHIQ) – a short measure of cluster headache related disability
por: Kamm, Katharina, et al.
Publicado: (2022)

Characteristics of migraine in patients with headache disorders: A clinic‐based study from Central American and Caribbean countries
por: Monterrey, Priscilla, et al.
Publicado: (2022)

Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype
por: Nagaraj, Karthik, et al.
Publicado: (2022)

Telephone follow‐up on treatment and patient satisfaction at a Danish tertiary headache center: A prospective study
por: Carlsen, Louise Ninett, et al.
Publicado: (2022)

Determining Thresholds for Meaningful Change for the Headache Impact Test (HIT‐6) Total and Item‐Specific Scores in Chronic Migraine
por: Houts, Carrie R., et al.
Publicado: (2020)

The effect of needle size on cerebrospinal fluid collection time and post‐dural puncture headache: A retrospective cohort study
por: van Dongen, Robin M., et al.
Publicado: (2021)

Development and Validation of the Cluster Headache Screening Questionnaire
por: Chung, Pil-Wook, et al.
Publicado: (2019)

Cluster headache
por: Leroux, Elizabeth, et al.
Publicado: (2008)

Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine
por: Ford, Janet H., et al.
Publicado: (2020)

A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache‐Related Disability
por: Lipton, Richard B., et al.
Publicado: (2016)

Smoking History and Clinical Features of Cluster Headache: Results from the Korean Cluster Headache Registry
por: Chung, Pil-Wook, et al.
Publicado: (2021)

Headache as a COVID‐19 onset symptom and post‐COVID‐19 symptom in hospitalized COVID‐19 survivors infected with the Wuhan, Alpha, or Delta SARS‐CoV‐2 variants
por: Fernández‐de‐las‐Peñas, César, et al.
Publicado: (2022)

Cluster headache with aura
por: Martínez-Fernández, Eva, et al.
Publicado: (2002)

Treatment of Cluster Headache
por: Kingston, William S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5tgg4tscg6civfva0fd9dovt4p